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ABSTRACT
Ventricular septal defect (VSD) is a congenital heart disease (CHD) which characterized by 
a hole in the wall that separate between the right and left ventricle. There are several types 
of VSD based on its location, which are perimembranous/conoventricular, subpulmonary/
conotruncal, supracristal/doubly commited, muscular and atrioventricular canal/inlet. A 
VSD is one of the most common CHD which occurs in approximately 2-6 of every 1,000 
live births and accounts for more than 20% of all CHDs. However, the population of VSD 
patients with grown up congenital heart disease (GUCH) is still uncertain. We are presenting 
a rare case of a 19 year old patient with congestive heart failure NYHA functional class IV 
due to uncorrected left-to-right shunt supracristal VSD with body mass index of 35.5 kg/
m2. He presented in the emergency room with acute decompensated heart failure profile 
B. Echocardiography revealed decreased left ventricle (LV) systolic function, normal right 
ventricle (RV) systolic function, decreased LV diastolic function, and dilated left atrium 
and LV. We plan to perform right heart catheterisation and pulmonary artery oxygen 
responsiveness test followed by VSD closure in this patient. Another explanation will be 
discussed in this paper.
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INTISARI
Defek septum ventrikel (DSV) adalah penyakit jantung bawaan (PJB) yang ditandai oleh 
adanya lubang pada dinding yang memisahkan antara ventrikel kanan dan kiri. Terdapat 
beberapa tipe DSV tergantung dari lokasinya, yaitu perimembran/konoventrikular, 
subpulmonal/konotrunkal, suprakrista/doubly committed, muskular dan kanal atrioventrikular/
inlet. DSV merupakan salah satu PJB yang sering ditemukan yaitu sekitar 2-6 dari setiap 
1.000 kelahiran hidup dan menjadi > 20% dari seluruh PJB. Namun, populasi DSV pada 
dewasa dengan PJB belum diketahui. Kami melaporkan sebuah kasus jarang pasien 19 
tahun dengan gagal jantung kongestif kelas fungsional NYHA IV karena DSV supracrista 
pirau kiri ke kanan yang tidak dikoreksi dengan indeks massa tubuh 35,5 kg/m2 yang datang 
ke unit gawat darurat. Ekhokardiografi menunjukkan penurunan fungsi ventrikel kiri, fungsi 
sistolik ventrikel kanan normal, penurunan fungsi diastolik ventrikel kiri dengan dilatasi 
atrium kiri dan ventrikel kiri. Kami merencanakan tindakan kateterisasi jantung kanan, tes 
reaktifitas oksigen dan penutupan DSV pada pasien ini. Beberapa penjelasan akan dibahas 
dalam laporan kasus ini.  
INTRODUCTION
Ventricular septal defect (VSD) is an 
acyanotic congenital heart disease (CHD) which 
results in left-to-right shunting. The changes 
in hemodynamic in patient with VSD depends 
on the size of the hole. A small restrictive VSD 
would result in high pressure gradient between 
the two ventricles and normally or mildly elevated 
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pulmonary arterial pressure. On the other hand, 
a larger and nonrestrictive VSD would permit 
equalize gradient between the ventricle and 
high pulmonary arterial pressure.1 When this 
happened, the right ventricle, pulmonary artery, 
left atrial and left ventricle would experience a 
relative volume overload. Overtime, the volume 
overload would cause chamber dilatation, 
systolic dysfunction and symptoms of heart 
failure.2 
Over 10% of infants with large VSD would 
develop early signs of heart failure which include 
tachypnea, poor feeding, frequent respiratory 
tract infection and eventually failure to thrive. 
But not all cases of VSD will result in failure to 
thrive.3 A recent research indicates that more 
than a quarter of children with CHD are also 
obese or overweight. There are two main causes 
have been described as the cause of obesity in 
this population: lack of physical activity and diet 
which often include consumption of increased 
calories and foods with high fat and sodium 
content. These individuals have an increase 
risk of developing atherosclerosis and other 
cardiovascular disease in the future.4,5
CASE PRESENTATION
A 19-year-old Balinese boy was brought to 
the emergency room due to chest pain, shortness 
of breath, orthopnea and cough, especially in 
night time that has lasted for 4 days. He had no 
family history of hypertension, diabetes mellitus, 
heart disease or asthma. He has a history of 
alcohol consumption for social occasion. Patients 
also have a history of fluctuate weight changing 
where patients have very low body mass index 
(BMI) when he was at early elementary school 
and become fat at late elementary school until 
junior high school. He stated that he was doing 
hard diet and exercise to become thin, but his 
heart condition getting worse, make him live 
a sedentary life and become obese. History 
of medication included spironolactone  50 mg 
q.i.d, furosemide 40 mg q.i.d, lisinopril 2.5 mg 
q.i.d, nebivolol 2.5 mg q.i.d and trimetazidine 
35 mg b.i.d. A physical examination done in the 
emergency room revealed a slightly elevated 
heart rate at 110 beats/min, blood pressure 
114/50 mmHg, respiratory rate 18 time/min, body 
weight 110 kg, body height 176 cm (BMI 35.5), 
oxygen saturation at 98% on O2 nasal canule 2 
l/min, jugular venous pressure 5 + 4 cmH2O, a 
grade 3 blowing pansystolic murmur at the apex, 
a rhales and a pretibial oedema. 
An initial electrocardiogram showed sinus 
tachycardia, left axis deviation and biphasic P wave 
in lead V2 (figure 1). Initial chest x-ray showed 
cardiomegaly and pulmonary oedema. Initial 
laboratory tests showed low haemoglobin count 
(10.95 g/dL), low hematocrit count (38.10%), low 
MCV (79.26 fL), low MCH (22.78 pg), low MCHC 
(28.74 g/dL), and high RDW (17.44%). 
Figure 1. Patients electrocardiogram showed sinus tachycardia with heart rate 110 beat/
min, biphasic p wave suggesting of left atrial enlargement, there was  also left axis deviation 
suggesting left ventricular enlargement
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At the ward, an echocardiography 
examination was done and showed dilatation of 
right atrium (RA), right ventricle (RV), left ventricle 
(LV) and left atrium (LA) dimension. The LV internal 
diameter on diastolic phase (LVIDd) was 6.51 
cm, LA diameter was 4.8 cm, RA ESA was 34.3 
cm2, and RV base was 4.94 cm. He also had low 
LV systolic function with LV ejection fraction (EF) 
35%, LV diastolic dysfunction with E/A ratio of 1.67, 
normal RV systolic function with TAPSE 2.0 cm, 
global hypokinesia, severe aortic regurgitation due 
to prolapse right coronary cusp with descending 
aorta diastolic reversal (AR VC 0.6 cm and AR 
PHT 219 m.s), tricuspid regurgitation (TR maximal 
pressure gradient (PG) 53 mmHg, TR maximal 
velocity 364 cm/s with hepatic vein systolic 
reversal), severe pulmonary regurgitation and 
normal mitral valve. We found a supracristal VSD 
with left to right shunt in a parasternal short axis 
view, in the level of aorta near pulmonary valve. 
We did not find shunting in interventricular septum 
in parasternal view, apical five chamber view, and 
apical four chamber view. There was no atrial 
septal defect and patent ductus arteriosus in this 
echo result. The movement of all 17 segments 
of the heart was decreased (global hypokinetic). 
We suggested a pulmonary hypertension with 
estimated systolic pulmonary arterial pressure 
(sPAP) of 63 mmHg. This echocardiogram 
result had significant differences with his last 
echocardiography from 2016, where his LVEF was 
still 59.8 %, and TR max PG of 3.6 mmHg (with 
estimated sPAP of 13.6 mmHg). Figure 2 shows 
the echocardiogram results.
   
Figure 2. Left panel figures are patient echocardiogram in 2017 and right panel figures are 
patient echocardiogram in 2016. There is the decrease in LVEF from 59.8% to 35% from 
previous echocardiogram to newer echocardiogram. We also can observe the supracristal VSD.
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The diagnosis of acute decompensated 
heart failure (ADHF) profile B caused by 
VSD was made. The patient was treated with 
intravenous NaCl 0.9%, O2 nasal canule 2 l/m, 
intravenous bolus of furosemide 100 mg then 
continued with intravenous drip furosemide 5mg/
hour, spironolactone 50 mg q.i.d, and ramipril 2.5 
mg q.i.d. Patient also presented with dyspepsia 
and was treated with sucralfat syrup 10 ml t.i.d 
and lansoprazol 30 mg q.i.d. We plan to do a 
pulmonary artery O2 responsiveness test in this 
patient, and if the result is positive, we plan to 
perform a VSD closure for this patient.
DISCUSSION
Obesity in Congenital Heart Disease (CHD)
Patients with CHD usually have a lower 
BMI than normal healthy child, but it does not 
mean that they are immune to obesity. Most 
people with CHD is restricted from participation in 
physical activity that may “stress the heart”. Their 
parents also tend to feed high calorie formulas 
because they think more weight children are 
safer and less fragile.3,4 A study conducted by 
Shustack et al.(2012) found that 8% of children 
with CHD have overweight and obesity, and they 
tend to be a boy rather than a girl.4 This condition 
can happen because of the restriction of physical 
activity or carry the stigma of heart disease where 
they may not be encouraged to participate in 
physical activity and live a relatively sedentary 
lifestyle.6 About 41% of parents were unable to 
identify their children activity restrictions. There is 
significantly fewer males with CHD participated in 
vigorous activity because of their parents fear of 
the damage heart.4 There are also a contribution 
from cardiologist to discuss about diet, nutrition 
and physical activity of patients with CHD. 
Only 63% of pediatric cardiologist discussed 
about the issues, another study found low rates 
of patients weight and diet counseling among 
CHD’s patients and cardiologist that lead to miss 
perception among parents that will make them 
give their child more calories while restricted their 
child activities.3,6 The CHD patients themselves 
show low rates of interest in physical activity. A 
study conducted by Dotje et al. (2014) showed 
that 69% of GUCH patients do not want to 
participate an exercise program. About 32% of 
patients who do not want to participate in physical 
activity fear of disease related symptom while 
24% just lack of interest in exercise. About 43% 
of them were satisfied with their physical fitness 
and 38% of them stated that they have lack of 
time to do the exercise.6
Ventricular Septal Defect
Ventricular septal defect (VSD) is the most 
common form of CHD. The prevalence of VSD 
in newborn babies is up to 5% by screening with 
highly sensitive colour doppler echocardiography 
although mostly are tiny muscular defects that 
disappear during the first year of life. VSD can be 
classifed into four main categories according to 
their location : perimembranous/conoventricular, 
subpulmonary/conotruncal, supracristal/doubly 
committed, muscular and atrioventricular canal/
inlet.1  Muscular defects are located within the 
muscular septum and they are surrounded by 
muscular rims. Perimembranous defects open 
into the right ventricle where the subpulmonary 
outflow tract turns superiorly relative to the 
atrioventricular junction. Doubly committed 
(subarterial or supracristal defects) lies caudal 
to the pulmonary valve in the infundibular 
portion of the right ventricular outflow tract.8 The 
location of the supracristal VSD with its close 
proximity to the aortic valve, accounts for the 
common development of right coronary cusp 
(RCC) prolapse with this defect. The absence 
of muscular septum below the adjacent aortic 
valve cusp is implicated because this results 
in unopposed downward force on the cusp 
during diastole, which progressively pull aortic 
valve tissue, especially RCC, through a venturi 
effect.7,8 Venturi effect is defined by reduction 
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in fluid pressure that results when a fluid flows 
through a constricted section. Recognition of the 
venturi effect as the most important mechanism 
in the pathogenesis of aortic valve prolapse 
(AVP) will aid in identification of patients at risk 
for development of aortic insufficiency and will 
predict both those patients in whom surgery 
is indicated as well as the timing of surgical 
intervention.8
Pulmonary Hypertension in VSD
Pulmonary hypertension (PH) is defined by 
increased in mean pulmonary arterial pressure 
(PAPm) ≥25 mmHg at rest as assessed by 
right heart catheterization (RHC). On the other 
hand, pulmonary arterial hypertension (PAH) 
describes a group of PH patients characterized 
haemodynamically by the presence of pre-
capillary PH, defined by a pulmonary artery 
wedge pressure (PAWP) ≤15 mmHg and a 
pulmonary vascular resistance (PVR)>3 Wood 
units (WU) in the absence of other causes of pre-
capillary PH such as PH due to lung diseases, 
chronic thromboembolic pulmonary hypertension 
(CTEPH) or other rare diseases.9 A restrictive 
VSD, defined as those with an orifice dimension 
less than or equal to 25% of the aortic annulus, 
would no cause pulmonary hypertension nor left 
ventricular volume overload. But on the other 
hand, a larger VSD generally cause moderate 
to larger left-to-right shunts with left ventricular 
overload and if remain uncorrected may cause 
severe pulmonary hypertension caused by 
longstanding obstructed pulmonary flow. With 
progressive pulmonary arterial hypertension, 
the right ventricular pressure can reach systemic 
levels leading to reversal of the shunt which 
would cause hypoxemia and cyanosis; this 
condition is known as Eisenmenger syndrome.10
Management of Pulmonary Hypertension in VSD 
Patients with pulmonary hypertension 
usually associated with RV failure. High 
resistance of the lungs causes the blood from 
RV difficult to enter pulmonary artery. It will 
causing overload of the RV, dilatation of RV 
wall, also decreasing contraction and function 
of the RV.5,7 Right ventricle failure affected blood 
volume that will enter LA. Small amount of blood 
volume which will enter the left chamber also 
impaired diastolic function of LV, and decrease 
cardiac output, making the systemic perfusion 
decrease and the heart more prone to ischemic 
because of flow decrease to the coronary artery 
during systolic phase.5 Pulmonary hypertension 
affects oxygenation of the blood. High resistance 
of the lung and alveolar will decrease the amount 
of deoxygenated blood that will be oxygenated in 
alveolus. It directly lowers systemic oxygenation.7 
Low oxygenation and perfusion affect Quality of 
Live (QoL) in patients with PH, they tend to have 
a lower capacity in exercise, also limitation in 
daily activity.8,10,12 In our case, patient almost 
sleep or rest for the whole day and experience 
a great dyspnea in every activity, it also affected 
his social live where he could not go out with his 
friends anymore. It also had a contribution to 
his obesity where his sedentary life made him 
gaining weight more and more.
Patients with PH have several problems 
to undergo surgical procedure especially 
cardiac surgery procedure. Patients with PH 
relatively more prone to ischemic during the 
surgery because of it natural hemodynamic 
changes and anesthesia effect in depressing 
myocardial contraction during the surgery.9,10,13 
Patients undergoing cardiac surgical repair 
showing mortality rates of up to 25%, the risk 
of RV dysfunction and ischemia is significant 
particularly after extracorporeal circulation is 
stopped. Patients undergoing cardiac surgery 
also experience pulmonary vasoconstriction 
correlates with the induced endothelial injury 
which can make the patient more prone to have 
a thrombus and stroke after surgery.10,13 Pre-
operative hemodynamic goals for PH are MAP 
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>55-60mmHg, SBP >80mmHg, SvO2 92%-100%, 
RAP <10mmhg, MPAP <35mmHg, PVR/SVR 
<0.5, PCWP 8-12mmHg, and CI >2.2L/min/m2.9,14 
Our case also had a high risk for cardiac surgery 
for his VSD closure. If the wall of pulmonary 
artery had already been stiff and did not respond 
to the oxygen, it indicated that his mortality and 
risk for PH crisis were high.15,16To test the viability 
of the pulmonary artery, its needed O2 challenge 
test with cardiac catheterization . Vasodilator 
testing perform using nitric oxide and oxygen as 
a primary agent and administered via inhalation 
with concentration 20 or 40 parts per million. 
Vasoreactivity defined by a decrease in mPAP 
by 10 mmHg-40 mmHg during the test. The 
decrease of mPAP >40mmHg and PVRI > 8 was 
considered inreactive result, and have a risk to 
increase RV pressure after surgical repair.16,17,18 
His VSD which have a shunt direction from right 
to left help to reduce RV overload also decreased 
RV pressure and increased preload for left heart 
chamber. If his pulmonary artery wall had already 
been unresponsive during O2 challenge test, the 
closure of the VSD will increase RV pressure, 
decrease LV preload also cardiac output which 
render his prognosis getting worse.17,18
Effect of Obesity in Management and Prognosis 
of VSD with Pulmonary Hypertension
The current consensus of whether to 
close the shunt or not is determined pulmonary 
vascular resistance index (PVRi).  The decision 
to close the shunt is done when PVRi is < 4, and 
the closure is not done when PVRi is > 8, if PVRi 
is between 4-8 then the patient is individually 
evaluated.17,18 But there is still limited data on the 
usefulness of the vasoreactivity test.19 
Several studies have been conducted 
examining the effects of obesity with treatment 
of congenital heart disease. A multicenter 
retrospective cohort study of extreme low and 
high BMI association of adverse perioperative 
outcomes in patient undergoing congenital 
heart disease operation has been done. A 
study conducted by O’Byrne et al. (2017) 
concluded that obesity was associated with 
increased risk of composite adverse outcomes 
that are independent of other risk factors. The 
risk acquired seems to be different between 
younger population (children, adolescents, and 
young adults) with congenital heart disease 
and adults with acquired heart disease, with 
the younger population experienced shorter 
duration of morbidity.14  The risk associated with 
obesity and congenital heart disease does not 
mean decreasing BMI will give better outcomes, 
further study is warranted. Other study concluded 
obesity did not affect the mortality and short term 
outcomes with adult population, but there is an 
increase of renal impairment on obese severe 
congenital heart disease patient.20 Patient with 
congenital heart disease have an increased risk 
for developing metabolic syndrome, and may be 
because of several risk factors including exercise 
restriction and differing nutritional strategies in 
infancy.19,20 In our patient, the risk for metabolic 
syndrome is augmented by his obesity.  Obesity 
in congenital heart disease have also been seen 
to have lesser exercise time even with a milder 
disease severity.20
CONCLUSION
Patients with CHD do not always have low 
BMI, some of them tend to have higher BMI than 
average due to limitation on physical activity. 
The CHD patients with obesity have higher risk 
to acquire early coronary artery disease and 
metabolic disease. Obesity is increased risk of 
adverse outcome due to their disease.
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